Ever Supreme Bio Technology Co., Ltd (TPEX: 6712)

Ever Supreme Bio Technology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,239	14,338	15,025	13,013	9,856	9,043
Market Cap Growth	9.27%	-4.57%	15.46%	32.03%	8.99%	59.89%
Enterprise Value	13,597	13,324	13,889	11,764	9,488	8,387
Last Close Price	176.50	172.46	175.17	148.22	123.93	113.71
PE Ratio	28.15	26.28	72.44	33.20	-86.33	-89.93
PS Ratio	17.38	18.91	23.94	29.65	139.61	835.88
PB Ratio	9.24	7.78	8.38	6.86	12.62	10.69
P/FCF Ratio	34.07	34.47	47.55	97.32	-49.95	-71.33
P/OCF Ratio	38.03	34.00	47.07	95.90	-71.18	-74.48
EV/Sales Ratio	16.51	17.57	22.13	26.81	134.40	775.20
EV/EBITDA Ratio	31.45	37.25	45.20	83.16	-69.97	-67.96
EV/EBIT Ratio	33.80	39.45	48.94	101.24	-60.39	-61.90
EV/FCF Ratio	32.54	32.04	43.95	87.99	-48.09	-66.15
Debt / Equity Ratio	0.01	0.00	0.01	0.02	0.06	0.04
Debt / EBITDA Ratio	0.02	0.02	0.06	0.23	-	-
Debt / FCF Ratio	0.02	0.01	0.06	0.26	-0.22	-0.28
Asset Turnover	0.43	0.37	0.31	0.30	0.08	0.01
Inventory Turnover	2.64	3.48	2.94	4.19	3.52	-
Quick Ratio	3.17	6.20	8.28	14.58	10.73	20.73
Current Ratio	3.65	6.57	8.89	15.20	11.87	21.68
Return on Equity (ROE)	30.34%	29.68%	10.88%	27.60%	-13.13%	-10.60%
Return on Assets (ROA)	13.19%	10.43%	8.88%	5.04%	-11.10%	-9.12%
Return on Capital (ROIC)	14.85%	11.54%	9.48%	5.27%	-11.51%	-9.34%
Earnings Yield	3.55%	3.76%	1.34%	2.84%	-1.08%	-1.04%
FCF Yield	2.93%	2.90%	2.10%	1.03%	-2.00%	-1.40%
Dividend Yield	3.07%	3.16%	0.94%	2.54%	-	-
Payout Ratio	86.16%	25.27%	154.19%	-	-	-
Buyback Yield / Dilution	1.60%	0.84%	-0.15%	-11.01%	-0.09%	-6.37%
Total Shareholder Return	4.68%	4.01%	0.80%	-8.47%	-0.09%	-6.37%

Source: S&P Capital IQ. Standard template. Financial Sources.